Search

Shuai Chen Phones & Addresses

  • Eastvale, CA
  • Corona, CA
  • Dayton, NJ
  • North Brunswick, NJ
  • Brooklyn, NY
  • 663 61St St APT 1, Brooklyn, NY 11220

Publications

Us Patents

Substituted Pyridinone-Containing Trycyclic Compounds, And Methods Using Same

View page
US Patent:
20200261432, Aug 20, 2020
Filed:
Mar 30, 2020
Appl. No.:
16/834577
Inventors:
- Burnaby, CA
Yingzhi Bi - Plainsboro NJ, US
Shuai Chen - Warrington PA, US
Bruce D. Dorsey - Ambler PA, US
Dimitar B. Gotchev - Hatboro PA, US
Richard James Holland - Vancouver, CA
Ramesh Kakarla - Doylestown PA, US
Duyan Nguyen - Ambler PA, US
Mark Christopher Wood - Port Moody, CA
Assignee:
Arbutus Biopharma Corporation - Burnaby
International Classification:
A61K 31/4375
C07F 9/6561
C07D 513/14
C07D 495/14
C07D 491/22
C07D 491/147
C07D 471/14
A61K 31/7105
A61K 31/683
A61K 9/51
A61P 31/20
Abstract:
The present invention includes substituted pyridinone-containing tricyclic compounds, and compositions comprising the same, that can be used to treat or prevent hepatitis B virus (HBV) infection in a patient. In certain embodiments, the compounds and compositions of the invention inhibit and/or reduce HBsAg secretion.

Substituted Pyridinone-Containing Trycyclic Compounds, And Methods Using Same

View page
US Patent:
20190314347, Oct 17, 2019
Filed:
Nov 3, 2017
Appl. No.:
16/347766
Inventors:
- Burnaby, CA
Yingzhi BI - Plainsboro NJ, US
Shuai CHEN - Wyncote PA, US
Bruce D. DORSEY - Ambler PA, US
Dimitar B. GOTCHEV - Hatboro PA, US
Richard James HOLLAND - Vancouver, British Columbia, CA
Ramesh KAKARLA - Doylestown PA, US
Duyan NGUYEN - Ambler PA, US
Mark Christopher WOOD - Port Moody, British Columbia, CA
International Classification:
A61K 31/4375
C07D 471/14
C07D 495/14
C07D 513/14
C07D 491/147
C07D 491/22
C07F 9/6561
A61K 31/683
A61K 31/7105
A61K 9/51
A61P 31/20
Abstract:
The present invention includes substituted pyridinone-containing tricyclic compounds, and compositions comprising the same, that can be used to treat or prevent hepatitis B virus (HBV) infection in a patient. In certain embodiments, the compounds and compositions of the invention inhibit and/or reduce HBsAg secretion.
Shuai Chen from Eastvale, CA, age ~35 Get Report